Literature DB >> 11223087

Partial purification and characterization of a hemolysin (CAH1) from Hawaiian box jellyfish (Carybdea alata) venom.

J J Chung1, L A Ratnapala, I M Cooke, A A Yanagihara.   

Abstract

We have isolated and characterized a novel hemolytic protein from the venom of the Hawaiian box jellyfish (Carybdea alata). Hemolysis of sheep red blood cells was used to quantitate hemolytic potency of crude venom extracted from isolated nematocysts and venom after fractionation and purification procedures. Hemolytic activity of crude venom was reduced or lost after exposure to the proteolytic enzymes trypsin, collagenase and papain. The activity exhibited lectin-like properties in that hemolysis was inhibited by D-lactulose and certain other sugars. Activity was irreversibly lost after dialysis of crude venom against divalent-free, 20mM EDTA buffer; it was optimal in the presence of 10mM Ca2+ or Mg2+. Two chromatographic purification methods, size fractionation on Sephadex G-200 and anion exchange with quaternary ammonium, provided fractions in which hemolytic activity corresponded to the presence of a protein band with an apparent molecular weight of 42kDa by SDS-PAGE. We have designated this protein as CAH1. The N-terminal sequence of CAH1 was determined to be: XAADAXSTDIDD/GIIG.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11223087     DOI: 10.1016/s0041-0101(00)00237-3

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  28 in total

1.  Chironex fleckeri (box jellyfish) venom proteins: expansion of a cnidarian toxin family that elicits variable cytolytic and cardiovascular effects.

Authors:  Diane L Brinkman; Nicki Konstantakopoulos; Bernie V McInerney; Jason Mulvenna; Jamie E Seymour; Geoffrey K Isbister; Wayne C Hodgson
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

Review 2.  Immunological and toxinological responses to jellyfish stings.

Authors:  James Tibballs; Angel A Yanagihara; Helen C Turner; Ken Winkel
Journal:  Inflamm Allergy Drug Targets       Date:  2011-10

3.  Active nematocyst isolation via nudibranchs.

Authors:  Ami Schlesinger; Esti Kramarsky-Winter; Yossi Loya
Journal:  Mar Biotechnol (NY)       Date:  2009-01-30       Impact factor: 3.619

Review 4.  Mediterranean jellyfish venoms: a review on scyphomedusae.

Authors:  Gian Luigi Mariottini; Luigi Pane
Journal:  Mar Drugs       Date:  2010-04-04       Impact factor: 5.118

5.  Evolution of box jellyfish (Cnidaria: Cubozoa), a group of highly toxic invertebrates.

Authors:  Bastian Bentlage; Paulyn Cartwright; Angel A Yanagihara; Cheryl Lewis; Gemma S Richards; Allen G Collins
Journal:  Proc Biol Sci       Date:  2009-11-18       Impact factor: 5.349

6.  Marine Neurotoxins: Envenomations and Contact Toxins.

Authors:  Michael R. Watters; Elijah W. Stommel
Journal:  Curr Treat Options Neurol       Date:  2004-03       Impact factor: 3.598

7.  Analgesic and antibutyrylcholinestrasic activities of the venom prepared from the Mediterranean jellyfish Pelagia noctiluca (Forsskal, 1775).

Authors:  Yosra Ayed; Afef Dellai; Hedi Ben Mansour; Hassen Bacha; Salwa Abid
Journal:  Ann Clin Microbiol Antimicrob       Date:  2012-06-12       Impact factor: 3.944

8.  Phylogenetic and Selection Analysis of an Expanded Family of Putatively Pore-Forming Jellyfish Toxins (Cnidaria: Medusozoa).

Authors:  Anna M L Klompen; Ehsan Kayal; Allen G Collins; Paulyn Cartwright
Journal:  Genome Biol Evol       Date:  2021-06-08       Impact factor: 3.416

9.  Cubozoan venom-induced cardiovascular collapse is caused by hyperkalemia and prevented by zinc gluconate in mice.

Authors:  Angel A Yanagihara; Ralph V Shohet
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

10.  Characteristics of hemolytic activity induced by skin secretions of the frog Kaloula pulchra hainana.

Authors:  Shuangshuang Wei; Tingting Chi; Aiyun Meng; Congwei Chen; Tianchen An; Manchuriga Wang; Yingxia Zhang
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2013-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.